COVID-19
FDA approves Abbott’s rapid portable COVID-19 test
August 27, 2020Research and Development Abbott, COVID-19, FDA, test
The FDA has given emergency clearance for Abbott’s portable COVID-19 test that it will sell for just $5. The company’s …
75-year-old Nottinghamshire woman may be first known British victim of coronavirus
August 26, 2020Research and Development COVID-19, coronavirus
A 75-year-old woman from Nottinghamshire is thought to be the first British case and victim of COVID-19. She tested positive …
Pharmafile.com’s weekly COVID-19 news round-up
August 26, 2020Research and Development COVID, COVID-19, coronavirus
In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that …
Man in Hong Kong reinfected with COVID-19 four months after initially contracting the virus
August 25, 2020Manufacturing and Production COVID-19, coronavirus, infection
A man in Hong Kong has been reinfected with the coronavirus, stoking fears that immunity to the virus may be …
FDA grants emergency authorisation for coronavirus plasma treatment
August 24, 2020Sales and Marketing COVID-19, FDA, coronavirus
The FDA has issued an Emergency Use Authorization (EUA) for convalescent plasma to treat patients with COVID-19. The regulatory body …
Top Ten most popular articles on Pharmafile.com this week
August 21, 2020Medical Communications COVID-19, coronavirus
The top 10 news stories this week again focus on coronavirus vaccines and treatments, as professor Alexander Chuchalin has quit …
Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidate
August 19, 2020Research and Development AstraZeneca, Australia, COVID-19, pharma
Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership …
FDA approves Roche’s Enspryng for neuromyelitis optica
August 17, 2020Sales and Marketing COVID, COVID-19, coronavirus
The FDA has granted approval for Roche’s Enspryng for treating the central nervous system disorder neuromyelitis optica. The drug (satralizumab) …
Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine
August 14, 2020Medical Communications COVID, COVID-19, coronavirus, vaccines
The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …
Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals
August 14, 2020Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma
The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …
Top Ten most popular articles on Pharmafile.com this week
August 14, 2020Medical Communications COVID-19, coronavirus, pandemic
The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …
COVID-19 patients are experiencing long-term effects from the virus
August 13, 2020COVID, COVID-19, coronavirus
Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.
Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues
August 12, 2020Research and Development COVID-19, Gilead, pharma, remdesivir
New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …
Mexico to hold trials for Chinese and American COVID-19 vaccines
August 12, 2020Research and Development COVID-19, Mexico, Mexico coronavirus
Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …
Moderna commits 100 million COVID-19 vaccine doses to the US
August 12, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma
Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
